X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (162) 162
Newspaper Article (100) 100
Patent (14) 14
Publication (5) 5
Book / eBook (4) 4
Book Chapter (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (74) 74
humans (66) 66
female (50) 50
male (50) 50
aged (34) 34
middle aged (34) 34
melanoma (31) 31
oncology (26) 26
adult (23) 23
survival (22) 22
aged, 80 and over (21) 21
analysis (17) 17
surgery (17) 17
patients (16) 16
clinical trials (15) 15
acute kidney injury - therapy (14) 14
cancer (14) 14
mortality (14) 14
treatment outcome (14) 14
abridged index medicus (13) 13
care and treatment (13) 13
immunotherapy (13) 13
metastasis (13) 13
prospective studies (13) 13
risk factors (13) 13
medicine & public health (12) 12
metastases (12) 12
prognosis (12) 12
critical care medicine (11) 11
quality of life (11) 11
renal replacement therapy - methods (11) 11
research (11) 11
acute kidney injury (10) 10
australia (10) 10
critically-ill patients (10) 10
failure (10) 10
follow-up studies (10) 10
ipilimumab (10) 10
performing operations (10) 10
transporting (10) 10
trial (10) 10
young adult (10) 10
adolescent (9) 9
melanoma - pathology (9) 9
vehicles in general (9) 9
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (9) 9
acute kidney injury - mortality (8) 8
continuous renal replacement therapy (8) 8
dermatology (8) 8
management (8) 8
open-label (8) 8
public, environmental & occupational health (8) 8
safety (8) 8
statistics & probability (8) 8
surgical oncology (8) 8
survival rate (8) 8
time factors (8) 8
usage (8) 8
biopsy (7) 7
hemodialysis (7) 7
medicine, research & experimental (7) 7
retrospective studies (7) 7
urology & nephrology (7) 7
australia - epidemiology (6) 6
brain (6) 6
continuous venovenous hemofiltration (6) 6
disability (6) 6
drug therapy (6) 6
emergency medicine (6) 6
epidemiology (6) 6
health aspects (6) 6
incidence (6) 6
intensive care (6) 6
metaanalysis (6) 6
neoplasm staging (6) 6
nivolumab (6) 6
randomized controlled trials as topic (6) 6
risk assessment (6) 6
studies (6) 6
age (5) 5
anesthesiology (5) 5
brain neoplasms - secondary (5) 5
chemistry (5) 5
critical illness (5) 5
dabrafenib (5) 5
dialysis (5) 5
hospitals (5) 5
impact (5) 5
intensive care units (5) 5
melanoma - mortality (5) 5
melanoma - secondary (5) 5
metallurgy (5) 5
multicenter (5) 5
multivariate analysis (5) 5
patient outcomes (5) 5
pediatrics (5) 5
proportional hazards models (5) 5
quality-of-life (5) 5
regression analysis (5) 5
research design (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2018, Volume 36, Issue 7, pp. 722 - 723
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. 672 - 681
Nivolumab monotherapy and combination nivolumab plus ipilimumab increase proportions of patients achieving a response and survival versus ipilimumab in... 
TRIAL | DABRAFENIB | SURVIVAL | ONCOLOGY | MUTANT MELANOMA | TRAMETINIB | DOUBLE-BLIND | OPEN-LABEL | Brain | Analysis | Metastasis
Journal Article
JAMA DERMATOLOGY, ISSN 2168-6068, 04/2019, Volume 155, Issue 4, pp. 502 - 502
Journal Article
Interventions Économiques pour une Alternative Sociale, ISSN 0715-3570, 01/2019, Volume 61
The African countries of the Franc Zone are on the margin of the observed industrialization process in several developing countries around the world. This... 
Franc Zone | structural transformation | financial development | industrialization
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 5024 - 5033
Purpose: Disruption of PD-L1/cytotoxic T-cell PD-1 signaling by immune checkpoint inhibitors improves survival in cancer patients. This study sought to... 
BIOMARKERS | ACTIVATION | THERAPY | ONCOLOGY | EXPANSION | NIVOLUMAB | TIM-3 | CD8-Positive T-Lymphocytes - pathology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - administration & dosage | Melanoma - genetics | Immunotherapy | Adult | Female | Antibodies, Monoclonal, Humanized - adverse effects | Kaplan-Meier Estimate | Drug Resistance, Neoplasm - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Drug Resistance, Neoplasm - genetics | B7-H1 Antigen - antagonists & inhibitors | Antibodies, Monoclonal - administration & dosage | Biopsy | Melanoma - immunology | Melanoma - drug therapy | Aged | Biomarkers, Tumor - genetics | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | Biomarkers, Tumor - immunology | Programmed Cell Death 1 Receptor - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Cell survival | PD-1 protein | CD8 antigen | Medical treatment | Melanoma | Cytotoxicity | Lymphocytes T | Macrophages | Patients | Metastases | Signaling | Immune checkpoint | Lymphocytes | Experimental design | PD-L1 protein | Infiltration | Immune system | Cancer
Journal Article
Interventions Économiques pour une Alternative Sociale, ISSN 0715-3570, 01/2019, Volume 61
The African countries of the Franc Zone are on the margin of the observed industrialization process in several developing countries around the world. This... 
financial development | Franc Zone | structural transformation | industrialization
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2018, Volume 25, Issue S3, pp. 918 - 919
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2017, Volume 116, Issue 12, pp. 1558 - 1563
Journal Article
Journal Article